11/11
08:04 am
eypt
Rating for EYPT
Low
Report
Rating for EYPT
11/11
08:04 am
eypt
Rating for EYPT
Low
Report
Rating for EYPT
11/8
05:13 pm
eypt
Rating for EYPT
Low
Report
Rating for EYPT
10/29
08:00 am
eypt
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $28.00 price target on the stock.
Low
Report
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $28.00 price target on the stock.
10/29
06:58 am
eypt
Rating for EYPT
Low
Report
Rating for EYPT
10/25
08:37 am
eypt
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Medium
Report
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
10/16
10:31 am
eypt
Rating for EYPT
Medium
Report
Rating for EYPT
10/16
10:31 am
eypt
Rating for EYPT
Medium
Report
Rating for EYPT
10/16
08:44 am
eypt
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
High
Report
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
10/16
08:44 am
eypt
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
High
Report
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
8/28
08:20 am
eypt
Rating for EYPT
Medium
Report
Rating for EYPT
8/28
08:20 am
eypt
Rating for EYPT
Medium
Report
Rating for EYPT